Fennec Pharmaceuticals Inc. (FENC): R&D Expense
$250.0K
Year ended 2025-12-31
$216.0K
Trailing 12 months to 2026-06-30
-58.6%
3-year compound annual growth
-45.3%
5-year compound annual growth
-0.2%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $250.0K | -18.6% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $307.0K | +448.2% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $56.0K | -98.4% | 2025-03-26, From 2023-01-01 |
| 2022-12-31 | $3.53M | -29.1% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $4.98M | -2.4% | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | $5.11M | -9.0% | 2022-02-28, From 2020-01-01 |
| 2019-12-31 | $5.61M | +12.0% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $5.01M | +158.7% | 2020-02-14, From 2018-01-01 |
| 2017-12-31 | $1.94M | +310.2% | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | $472.0K | +84.4% | 2018-03-28, From 2016-01-01 |
| 2015-12-31 | $256.0K | -28.3% | 2017-03-29, From 2015-01-01 |
| 2014-12-31 | $357.0K | -38.3% | 2016-03-28, From 2014-01-01 |
| 2013-12-31 | $579.0K | -72.1% | 2014-03-31, From 2013-01-01 |
| 2012-12-31 | $2.08M | +38.9% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $1.49M | +111.0% | 2013-04-01, From 2011-01-01 |
| 2010-12-31 | $708.0K | n/a | 2012-03-27, From 2010-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | 2025-12-31 | $250.0K | -18.6% |
| Editas Medicine, Inc. (EDIT) | 2025-12-31 | $89.95M | -54.9% |
| Voyager Therapeutics, Inc. (VYGR) | 2025-12-31 | $134.67M | +5.7% |
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | $112.67M | +1.0% |
| Kymera Therapeutics, Inc. (KYMR) | 2025-12-31 | $316.57M | +31.8% |
| Protalix BioTherapeutics, Inc. (PLX) | 2025-12-31 | $19.57M | +50.9% |
| Invivyd, Inc. (IVVD) | 2025-12-31 | $38.31M | -72.1% |
| C4 Therapeutics, Inc. (CCCC) | 2025-12-31 | $104.24M | -5.8% |
| X4 Pharmaceuticals, Inc (XFOR) | 2025-12-31 | $72.72M | -10.9% |
Compare FENC, EDIT, VYGR, SGMOQ side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗